Blinatumomab
MCE 国际站:Blinatumomab
CAS:853426-35-4
品牌:MedChemExpress (MCE)
存储条件:Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性: Blinatumomab (Anatumomab) 是一种双特异性单克隆抗体,可特异性靶向存在于 B 细胞上的 CD19 抗原。 Blinatumomab可用于急性淋巴细胞白血病的研究[1]。
热销产品:Durvalumab | Mertansine | Futibatinib | BT2 | Plerixafor | Nocodazole | SAH | Acalabrutinib | Picrotoxin | Valinomycin
作用靶点:CD19
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
参考文献:
[1]. Kantarjian H, et, al. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. N Engl J Med. 2017 Mar 2;376(9):836-847.